Review on Effects of Chemotherapy Efficacy in Breast Cancer
Received Date: Jan 02, 2023 / Published Date: Jan 30, 2023
Abstract
A mutation in a known hereditary breast cancer predisposition gene, such as BRCA1 or BRCA2.1, is linked to between 5% and 10% of the 2.3 million breast cancer cases diagnosed annually2. The integration of genomics into the standard diagnostic pathways for breast cancer patients and the availability of targeted treatment approaches for those with hereditary breast cancer predisposition genes are two examples of the effects that chemotherapy has on breast cancer efficacy. These patients now require a different approach to care than they did a decade ago because of mutations. The most recent advances in systemic treatment for hereditary breast cancer are discussed in this review, as well as the challenges that must be overcome in the future to improve clinical outcomes for this particular subgroup
Citation: Richard J (2023) Review on Effects of Chemotherapy Efficacy in BreastCancer. Cancer Surg, 8: 048.
Copyright: © 2023 Richard J. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
51ºÚÁϳԹÏÍø Journals
Article Usage
- Total views: 1502
- [From(publication date): 0-2023 - Jun 22, 2025]
- Breakdown by view type
- HTML page views: 1162
- PDF downloads: 340
